Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. (Record no. 20004522)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01858 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250515233345.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201009s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1532-1827 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1038/sj.bjc.6605819 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Garrido-Laguna, I |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20100910 |
| 245 00 - TITLE STATEMENT | |
| Title | Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | British journal of cancer |
| Date of publication, distribution, etc. | Aug 2010 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 649-55 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adenocarcinoma |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibiotics, Antineoplastic |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gene Expression Profiling |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Intracellular Signaling Peptides and Proteins |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pancreatic Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Serine-Threonine Kinases |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Signal Transduction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sirolimus |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | TOR Serine-Threonine Kinases |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tan, A C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Uson, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Angenendt, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ma, W W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Villaroel, M C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zhao, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rajeshkumar, N V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jimeno, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Donehower, R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Iacobuzio-Donahue, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barrett, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rudek, M A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rubio-Viqueira, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Laheru, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hidalgo, M |
| 773 0# - HOST ITEM ENTRY | |
| Title | British journal of cancer |
| Related parts | vol. 103 |
| -- | no. 5 |
| -- | p. 649-55 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1038/sj.bjc.6605819">https://doi.org/10.1038/sj.bjc.6605819</a> |
| Public note | Available from publisher's website |
No items available.